Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
13.6M
-
Shares change
-
+827K
-
Total reported value, excl. options
-
$16.9M
-
Value change
-
-$51.5K
-
Number of buys
-
8
-
Number of sells
-
-13
-
Price
-
$1.24
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q1 2025
34 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q1 2025.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.6M shares
of 100M outstanding shares and own 13.55% of the company stock.
Largest 10 shareholders include UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (4.72M shares), Long Focus Capital Management, LLC (4.72M shares), B Group, Inc. (3.26M shares), MACQUARIE GROUP LTD (227K shares), BAILLIE GIFFORD & CO (139K shares), MILLENNIUM MANAGEMENT LLC (104K shares), MORGAN STANLEY (86.8K shares), LPL Financial LLC (84.7K shares), ACADIAN ASSET MANAGEMENT LLC (46.4K shares), and UBS Group AG (44.5K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.